Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-20
2007-02-20
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S381000, C514S383000, C514S400000, C514S407000, C514S427000, C546S334000, C548S253000, C548S267600, C548S338500, C548S375100, C548S561000
Reexamination Certificate
active
11081393
ABSTRACT:
The present invention is concerned with compounds of formulathe N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein X represents O, S or NR3; R1represents hydrogen, hydroxy, C1-6alkyl or aryl; R2represents hydrogen; optionally substituted C1-12alkyl; C3-7cycloalkyl; C2-8alkenyl; aryl; Het1; or R1and R2taken together may form a bivalent radical of formula —(CH2)n— wherein n is 2, 3, 4, 5 or 6; R3represents hydrogen, optionally substituted C1-6alkyl, aryl, Het1; R4represents hydrogen; hydroxy; mercapto; C1-6alkyloxy; C1-6alkylthio; aryloxy; arylthio; Het1-oxy; Het1-thio; optionally substituted C1-12alkyl; optionally substituted C2-8alkenyl; optionally substituted C2-8alkynyl; optionally substituted C3-7cycloalkyl; optionally substituted C5-7cycloalkenyl; aryl; Het1; or -Alk-NR3R5(i) or —NR3R5(ii) wherein Alk represents C1-6alkanediyl; and R5represents hydrogen, C1-6alkyl, aryl, Het1, (aryl or Het1)C1-6alkyl, (aryl or Het1)carbonyl or (aryl or Het1)C1-6alkyloxycarbonyl; aryl represents optionally substituted indanyl, indenyl, naphtyl, 5,6,7,8-tetrahydro-2-naphtalenyl or phenyl; Het represents an optionally substituted unsaturated heterocycle; and Het1represents an optionally substituted monocyclic or bicyclic heterocycle; having retinoic mimetic activity; their preparation, compositions containing them and their use as a medicine.
REFERENCES:
patent: 4788206 (1988-11-01), Guthrie et al.
patent: 0260774 (1988-03-01), None
patent: 0371559 (1990-06-01), None
patent: 0371564 (1990-06-01), None
patent: 52083565 (1977-07-01), None
patent: WO 97/16443 (1997-05-01), None
patent: WO 97/49704 (1997-12-01), None
English Abstract of Japanese Patent JP52083565; Publication Date Jul. 12, 1977; Applicant Kyowa Hakko Kogyo KK.
Adelinet Christophe Denis
Csoka Imré Christian
Mabire Dominique
Venet Marc Gaston
Davis Zinna N.
Janssen Pharmaceutica N.V.
LandOfFree
Retinoic acid mimetic anilides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoic acid mimetic anilides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoic acid mimetic anilides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3843917